Superior immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (inactivated)

Vaccine

Volumn 30, Issue 13, 2012, Pages 2329-2335

  Kikukawa, Akiko ^a   Gomi, Yasuyuki ^a   Akechi, Masateru ^a   Onishi, Toshiyuki ^a   Manabe, Sadao ^a   Namazue, Junko ^a   Fuke, Isao ^a   Ishikawa, Toyokazu ^a   Okuno, Yoshinobu ^a   Ueda, Shigeharu ^a  

^a Osaka University   (Japan)

Author keywords

Japanese encephalitis; Potency; Vaccine; Vero cells

Indexed keywords

JAPANESE ENCEPHALITIS VACCINE;

ANTIBODY TITER; ARTICLE; CELL CULTURE; CHILD; CONTROLLED STUDY; DOSE CALCULATION; DOSE RESPONSE; DRUG DOSE COMPARISON; FEMALE; FREEZE DRYING; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; JAPANESE ENCEPHALITIS; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CERCOPITHECUS AETHIOPS; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; FREEZE DRYING; HUMANS; IMMUNIZATION; INFANT; JAPANESE ENCEPHALITIS VACCINES; MICE; TREATMENT OUTCOME; VACCINES, INACTIVATED; VERO CELLS; VIRUS CULTIVATION;

EID: 84857787438     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.01.054     Document Type: Article

References (17)

1. WHO Wkly Epidemiol Rec 2006, 34/35(81):325-340.
2. Solomon T. Control of Japanese encephalitis-within our grasp?. N Engl J Med 2006, 355(August (9)):869-871.
3. WHO Recommendations for Japanese Encephalitis Vaccine (inactivated) for human use. Expert Committee on Biological Standardization, Geneva, October 8-12 2007.
4. Ohtaki E., Matsuishi T., Hirano Y., Maekawa K. Acute disseminated encephalomyelitis after treatment with Japanese B encephalitis vaccine (Nakayama-Yoken and Beijing strains). J Neurol Neurosurg Psychiatry 1995, 59(September (3)):316-317.
5. Ohtaki E., Murakami Y., Komori H., Yamashita Y., Matsuishi T. Acute disseminated encephalomyelitis after Japanese B encephalitis vaccination. Pediatr Neurol 1992, 8(March-April (2)):137-139.
6. WHO Wkly Epidemiol Rec 2005, 28(80):241-248.
7. Halstead S.B., Thomas S.J. New Japanese encephalitis vaccines: alternatives to production in mouse brain. Expert Rev Vaccines 2011, 10(March (3)):355-364.
8. Appaiahgari M.B., Vrati S. IMOJEV((R)): a yellow fever virus-based novel Japanese encephalitis vaccine. Expert Rev Vaccines 2010, 9(December (12)):1371-1384.
9. Hombach J., Solomon T., Kurane I., Jacobson J., Wood D. Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, September 2-3, 2004. Vaccine 2005, 23(November (45)):5205-5211.
10. Oya A. Japanese encephalitis vaccine. Acta Paediatr Jpn 1988, 30(April (2)):175-184.
11. Kurane I., Takasaki T. Immunogenicity and protective efficacy of the current inactivated Japanese encephalitis vaccine against different Japanese encephalitis virus strains. Vaccine 2000, 18(May (Suppl. 2)):33-35.
12. Markoff L. Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccines. Vaccine 2000, 18(May (Suppl. 2)):26-32.
13. Ferguson M., Kurane I., Wimalaratne O., Shin J., Wood D. WHO informal consultation on the scientific basis of specifications for production and control of inactivated Japanese encephalitis vaccines for human use, Geneva, Switzerland, June 1-2, 2006. Vaccine 2007, 25(July (29)):5233-5243.
14. Van Gessel Y., Klade C.S., Putnak R., Formica A., Krasaesub S., Spruth M., et al. Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO((R))) induced neutralizing antibody titers. Vaccine 2011, 29(August (35)):5925-5931.
15. WHO. World Health Organization Technical Report Series, No.771 Annex 6 Requirement for Japanese Encephalitis Vaccine (Inactivated) for Human Use 1988.
16. Kimura-Kuroda J., Yasui K. Topographical analysis of antigenic determinants on envelope glycoprotein V3 (E) of Japanese encephalitis virus, using monoclonal antibodies. J Virol 1983, 45(January (1)):124-132.
17. Kimura-Kuroda J., Yasui K. Antigenic comparison of envelope protein E between Japanese encephalitis virus and some other flaviviruses using monoclonal antibodies. J Gen Virol 1986, 67(December (Pt. 12)):2663-2672.